10:25:00 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Cellular Dynamics International, Inc. - ICEL

2015-03-30 15:40 ET - News Release

NEW YORK, March 30, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cellular Dynamics International, Inc. ("Cellular Dynamics" or the "Company") (NASDAQ: ICEL) (ISIN: US15117V1098) (CUSIP: 15117V109) concerning the proposed acquisition of Cellular Dynamics by Fujifilm Holdings Corporation.

Cellular Dynamics shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at rswilloughby@pomlaw.com or 212-661-1100 or 888-476-6529, ext. 237.

The investigation concerns whether the Cellular Dynamics directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value.   Under the terms of the proposed transaction, Cellular Dynamics shareholders will receive $16.50 per share in cash for each share of Cellular Dynamics common stock.  However, an analyst recently set a price target for Cellular Dynamics at $24.07 a share. Moreover, the total assets and book value multiples are below the averages of comparable transactions, according to a Bloomberg analysis.

Pomerantz LLP, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz LLP pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz LLP continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.

CONTACT:
Robert Willoughby
Pomerantz LLP
212-661-1100 ext. 237
rswilloughby@pomlaw.com

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-llp-investigates-claims-that-the-merger-may-not-be-in-the-best-interest-of-investors-of-cellular-dynamics-international-inc--icel-300057857.html

SOURCE Pomerantz LLP

© 2024 Canjex Publishing Ltd. All rights reserved.